ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ТЕРАПИИ (обзор литературы, часть IV)
https://doi.org/10.51523/2708-6011.2011-8-1-3
Аннотация
В обзоре представлена информация о современной медикаментозной и инструментальной терапии острого коронарного синдрома (ОКС).
Список литературы
1. The SHOCK Trial Study Group Should we emergently revascularize Occluded Coronaries for cardiogenic shock: an international randomized trial of emergency PTCA/CABS-trial design / J. S. Hochman [et al.] // Am. Heart J. - 1999. - Vol. 137. - P. 313-321.
2. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial / J. J. Goy [et al.] / J. Am. Coll. Cardiol. - 2005. - Vol. 18(45). - P. 308-311.
3. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent / L. Ge [et al.] / J. Am. Coll. Cardiol. - 2005. - Vol. 95(6). - P. 757-760.
4. Nordmann, A. J. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis / A. J. Nordmann, M. Briel, H. C. Bucher // Eur. Heart J. - 2006. - Vol. 27. - P. 2784-2814.
5. Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trial / S. R. Mehta [et al.] // J.A.M.A. - 2005. - Vol. 293. - P. 2908-2917.
6. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents / G. W. Stone // N. Engl. J. Med. - 2007. - Vol. 356. - P. 998-1008.
7. Serruys, P. W. Coronary-artery stents / P. W. Serruys, M. J. B. Kutryk, A. T. L. Ong // N. Engl. J. Med. - 2006. - Vol. 354. - P. 483-495.
8. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis / E. Ferrari [et al.] / J. Am. Cardiol. - 2005. - Vol. 45. - P. 456-459.
9. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS) / D. A. Morrow [et al.] // Am. J. Cardiol. - 2004. - Vol. 359. - P. 774-776.
10. Рекомендации Европейского Кардиологического общества по проведению перкутанных коронарных вмешательств / В. Г. Терентьев. - Киев, 2005. - 84 с.
11. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery / D. M. Bravata [et al.] // Ann. Intern. Med. - 2007. - Vol. 147. - P. 703-716.
12. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal / W. J. Cantor [et al.] // Catheter. Cardiovasc. Interv. - 2006. - Vol. 69. - P. 73-83.
13. Trombolysis (PCAT)-2 Trialists` Collaboraive Group. Does Time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients / E. Boersma [et al.] // Eur. Heart J. - 2006. - Vol. 27. - P. 779-788.
14. Сергеев, Г. А. Интервенционные и хирургические методы лечения больных с острым коронарным синдромом при множественном поражении коронарных артерий / Г. А. Сергеев, Л. Г. Гелис, Ю. П. Островский // Мед. панорама. - 2006. - № 11. - С. 17-19.
15. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease / P. W. Serruys [et al.] // N. Engl. J. Med. - 2001. - Vol. 344. - P. 1117-1124.
16. Effect of coronary artery bypass graft surgery on survival-overview of 10-year result from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration / S. Yusuf [et al.] // Lancet. - 1994. - Vol. 344. - P. 563-570.
17. Long-term potency of internal mammary artery bypass grafts: relationship with preoperative severity of native coronary artery stenosis / A. Berger [et al.] // Circulation. - 2004. - Vol. 14. - P. 36-40.
18. Arterial revascularization with the right gastroepiploic artery and internal mammary arteries in 300 patients / J. Grandjean [et al.] // J. Thor. Cardiov. Surg. - 1994. - Vol. 107. - P. 1309-1316.
19. Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VAHQWISH trial / A. Goyal [et al.] // J. Am. Coll. Cardiol. - 2002. - Vol. 39. - P. 1601-1607.
20. Coronary revascularization in diabetic patients - a comparison of the randomized and observation components of the Bypass Angioplasty Revascularization Investigation (BARI) / K. M. Detre [et al.] // Circulation. - 1999. - Vol. 99. - P. 633-640.
21. CABRI Trial Participants First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation) // Lancet. - 1995. - Vol. 346. - P. 1179-1184.
22. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial Investigators of the Department of Veterans Affairs Cooperative Study № 385, the Angina With Extremely Serious Operative Evaluation (AWESOME) / D. A. Morrison [et al.] // J. Am. Coll. Cardiol. - 2001. - Vol. 38. - P. 143-149.
23. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery disease: a meta-analysis with 5-year patients-level data from the ARTS, ERACI-II, MASS-II, and SoS trials / J. Daemen [et al.] // Circulation. - 2008. - Vol. 118. - P. 1146-1154.
24. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (S0S) / J. Booth [et al.] // Circulation. - 2008. - Vol. 118. - P. 381-388.
25. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease-one-year results / W. Hueb [et al.] // J. Am. Coll. Cardiol. - 2004. - Vol. 43. - P. 1743-1751.
26. Does clopidogrel increase blood loss following coronary artery bypass surgery? / M. W. Chu [et al.] // Ann. Thorac. Surg. - 2004. - Vol. 78. - P. 1536-1541.
27. European Guidelines on cardiovascular disease prevention in clinical practice: executive summary / Eur. Heart J. - 2007. - Vol. 28. - P. 2375-2414.
28. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism / P. Poirier [et al.] // Circulation. - 2006. - Vol. 113. - P. 898-918.
29. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association / R. H. Eckel [at al.] // Circulation. - 2006. - Vol. 113. - P. 2943-2946.
30. Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels / N. Engl. J. Med. - 1998. - Vol. 339. - P. 1349-1357.
Рецензия
Для цитирования:
Саливончик Д.П. ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ТЕРАПИИ (обзор литературы, часть IV). Проблемы здоровья и экологии. 2011;(1):20-26. https://doi.org/10.51523/2708-6011.2011-8-1-3
For citation:
Salivonchik D.P. THE ACUTE CORONARY SYNDROME: POSSIBILITY UP-TO-DATE POTENTIAL OF THE THERAPY (literature review. Part IV). Health and Ecology Issues. 2011;(1):20-26. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-1-3
Просмотров: 252
Послать статью по эл. почте 